ALB and hepatocellular carcinoma: This 3-lncRNA-based signature was more suitable for patients with higher serum levels of AFP (>20 ng/mL) and relatively lower levels of albumin (<4.0 g/dL) or Asian patients with no family history of HCC or history of alcohol consumption.